Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 775
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
for
Advanced Solid Tumor,
Location: Washington D.C. DC, Morristown NJ, Cleveland OH,
Sponsor: Vaxiion Therapeutics
Sex: All
Age: 18+
Code: NCT05901285
Phase 1, Recruiting
CtDNA Based MRD Testing for NAC Monitoring in TNBC
for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: Washington DC DC, York PA, Stony Brook NY, Ypsilanti MI,
Sponsor: Personalis Inc.
Sex: Female
Age: 18+
Code: NCT06230185
Recruiting
New
Society of Thoracic Surgeons and American College of Cardiology Transcatheter Valve Therapy Registry (STS/ACC TVT Registry™): Registry Purpose and Research Objective
for
Aortic Valve Stenosis
Location: Washington D.C. DC
Sponsor: American College of Cardiology
Sex: All
Age: 18+
Code: NCT07908355
Recruiting
STS/ACC TVT Registry Mitral Module
for
Mitral Valve Regurgitation
Location: Washington D.C. DC
Sponsor: American College of Cardiology
Sex: All
Age: 1+
Code: NCT02245763
Recruiting
Left Atrial Appendage Occlusion Registry (LAAO Registry)
for
Atrial Fibrillation
Location: Washington D.C. DC
Sponsor: American College of Cardiology
Sex: All
Age: 18+
Code: NCT02699957
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Location: Washington DC, Durham NC, Cleveland OH, Asheville NC,
Sponsor: Potrero Medical
Sex: All
Age: 18+
Code: NCT04669548
Recruiting
Prevention of Postpartum Hemorrhage With Tranexamic Acid
for
Post Partum Hemorrhage
Location: Washington D.C. DC, Falls Church VA
Sponsor: Inova Health Care Services
Sex: Female
Age: 18 - 50
Code: NCT05370820
Phase 2, Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
for
Prostate Cancer (Adenocarcinoma)
Location: Washington D.C. DC, Baltimore MD, Elkton MD,
Sponsor: Canadian Cancer Trials Group
Sex: Male
Age: 18+
Code: NCT06592924
Phase 3, Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Washington D.C. DC, Baltimore MD, Gettysburg PA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06532279
Phase 2, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Washington D.C. DC, Largo MD, Columbia MD,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase 3, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Washington D.C. DC, Baltimore MD, Frederick MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase 2, Phase 3, Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Washington D.C. DC, Falls Church VA, Richmond VA,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT03907046
Phase 3, Recruiting
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
for
Metastatic Colorectal Adenocarcinoma,
Location: Washington D.C. DC, Mechanicsville VA, Newark DE,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT05673148
Phase 2, Recruiting
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
for
Advanced Lung Non-Small Cell Carcinoma,
Location: Washington D.C. DC, Baltimore MD, Westminster MD,